Nina Capital

Nina Capital is a Barcelona-based venture capital firm with a distinct focus on the health technology sector, investing in need-driven founders who are building companies with significant international ambitions. The firm positions itself as a specialized investor, providing capital and strategic support to startups that are poised to transform healthcare through innovation. Their investment scope is broad within health tech, encompassing areas such as digital health, medical devices, diagnostics, biotech, and pharma services, reflecting a comprehensive approach to the evolving healthcare landscape.

The firm primarily targets early-stage companies, with a strong emphasis on Seed and Series A rounds. Nina Capital typically deploys initial cheques ranging from €500,000 to €2 million, while also reserving capital for subsequent follow-on investments to support their portfolio companies' growth trajectories. Geographically, their investment mandate extends across Europe and North America, seeking out promising ventures in these key innovation hubs. This strategic focus allows them to leverage their deep industry knowledge and operational experience to guide founders through the complexities of the health tech market.

Nina Capital manages multiple funds, collectively overseeing over €100 million in capital dedicated to health tech innovation. Their second fund, Nina Capital Fund II, successfully closed at €40 million, demonstrating investor confidence in their specialized strategy. Building on this momentum, the firm has recently launched Nina Capital Fund III, which is targeting a substantial €80 million to further expand its investment capacity. With a portfolio already exceeding 30 companies, Nina Capital has established itself as a significant player in the global health tech venture ecosystem, actively contributing to the development of solutions that address critical healthcare needs.